Athira Pharma to Present at H.C. Wainwright & Co. Global Life Sciences Conference
March 02 2021 - 6:00AM
Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage
biopharmaceutical company focused on developing small molecules to
restore neuronal health and stop neurodegeneration, today announced
that Leen Kawas, Ph.D., President and Chief Executive Officer, will
present a corporate overview during the H.C. Wainwright & Co.
Global Life Sciences Conference. A pre-recorded presentation will
be available for on-demand viewing beginning at 7:00 am ET on
Tuesday, March 9, 2021.
A webcast of the presentation will also be available on the
Investors section of the Athira website at
https://investors.athira.com/news-and-events/events-and-presentations.
An archived replay of the webcast will be available for
approximately 90 days following the event.
About Athira Pharma, Inc.Athira, headquartered
in Seattle, is a late clinical-stage biopharmaceutical company
focused on developing small molecules to restore neuronal health
and stop neurodegeneration. We aim to provide rapid cognitive
improvement and alter the course of neurological diseases with our
novel mechanism of action. Athira is currently advancing its lead
therapeutic candidate, ATH-1017, a novel small molecule for
Alzheimer’s and Parkinson’s dementia. For more information,
visit www.athira.com. You can also follow Athira
on Facebook, LinkedIn and @athirapharma
on Twitter and Instagram.
Investor & Media Contact:Julie
RathbunAthira PharmaJulie.rathbun@athira.com206-769-9219
Athira Pharma (NASDAQ:ATHA)
Historical Stock Chart
From May 2024 to Jun 2024
Athira Pharma (NASDAQ:ATHA)
Historical Stock Chart
From Jun 2023 to Jun 2024